FDA, aiming to lower drug costs, moves to speed approval of biosimilars

The agency will no longer require studies comparing copycat biologics to their branded counterparts, which could help developers bring them to market more quickly and cheaply.

Akeso claims another PD-1/VEGF win; FDA requests more data from Novavax

Lyell starts first-of-its-kind CAR-T trial; New coalition aims to boost European biotechs

February 13, 2026

GCF announces commitment to mobilise $100m for Chad – EnviroNews

February 13, 2026

Source link

FDA, aiming to lower drug costs, moves to speed approval of biosimilars

Lyell starts first-of-its-kind CAR-T trial; New coalition aims to boost European biotechs

GCF announces commitment to mobilise $100m for Chad – EnviroNews

Phia’s founders on how AI is changing online shopping

HASC members beg Boeing to negotiate end to ‘disruptive’ fighter-jet worker strike

HASC members beg Boeing to negotiate end to ‘disruptive’ fighter-jet worker strike

Leave a Reply Cancel reply

RECOMMENDED NEWS

Driving Greater Access To Digital Skills

FBI’s WMD Program Has a New Target: Animal Rights Activists

Oceanbase Supports Palmpay to Reduce Its Database Cost by 80%

Melatonin Enhances Memory – Neuroscience News

POPULAR NEWS

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

When Will SHIB Reach $1? Here’s What ChatGPT Says

FDA, aiming to lower drug costs, moves to speed approval of biosimilars

Related posts

Phia’s founders on how AI is changing online shopping

HASC members beg Boeing to negotiate end to ‘disruptive’ fighter-jet worker strike

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS